128 related articles for article (PubMed ID: 17632196)
1. Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies.
Rademeyer C; Moore PL; Taylor N; Martin DP; Choge IA; Gray ES; Sheppard HW; Gray C; Morris L; Williamson C;
Virology; 2007 Nov; 368(1):172-81. PubMed ID: 17632196
[TBL] [Abstract][Full Text] [Related]
2. Extensive cross-reactive neutralizing antibody response in Indian patients with limited genetic diversity of HIV-1.
Lakhashe SK; Kulkarni SS; Thakar MR; Ghate MV; Paranjape RS
Virology; 2007 Mar; 359(2):295-301. PubMed ID: 17074379
[TBL] [Abstract][Full Text] [Related]
3. Comparisons of the genetic and neutralization properties of HIV-1 subtype C and CRF07/08_BC env molecular clones isolated from infections in China.
Wang S; Nie J; Wang Y
Virus Res; 2011 Jan; 155(1):137-46. PubMed ID: 20875470
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry.
Blish CA; Nedellec R; Mandaliya K; Mosier DE; Overbaugh J
AIDS; 2007 Mar; 21(6):693-702. PubMed ID: 17413690
[TBL] [Abstract][Full Text] [Related]
5. Neutralization and infectivity characteristics of envelope glycoproteins from human immunodeficiency virus type 1 infected donors whose sera exhibit broadly cross-reactive neutralizing activity.
Cham F; Zhang PF; Heyndrickx L; Bouma P; Zhong P; Katinger H; Robinson J; van der Groen G; Quinnan GV
Virology; 2006 Mar; 347(1):36-51. PubMed ID: 16378633
[TBL] [Abstract][Full Text] [Related]
6. Analysis of HIV-1 subtype B third variable region peptide motifs for induction of neutralizing antibodies against HIV-1 primary isolates.
Haynes BF; Ma B; Montefiori DC; Wrin T; Petropoulos CJ; Sutherland LL; Scearce RM; Denton C; Xia SM; Korber BT; Liao HX
Virology; 2006 Feb; 345(1):44-55. PubMed ID: 16242749
[TBL] [Abstract][Full Text] [Related]
7. Ancestral and consensus envelope immunogens for HIV-1 subtype C.
Kothe DL; Li Y; Decker JM; Bibollet-Ruche F; Zammit KP; Salazar MG; Chen Y; Weng Z; Weaver EA; Gao F; Haynes BF; Shaw GM; Korber BT; Hahn BH
Virology; 2006 Sep; 352(2):438-49. PubMed ID: 16780913
[TBL] [Abstract][Full Text] [Related]
8. Multi-subtype gp160 DNA immunization induces broadly neutralizing anti-HIV antibodies.
Rollman E; Hinkula J; Arteaga J; Zuber B; Kjerrström A; Liu M; Wahren B; Ljungberg K
Gene Ther; 2004 Jul; 11(14):1146-54. PubMed ID: 15103320
[TBL] [Abstract][Full Text] [Related]
9. Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines.
Brown BK; Darden JM; Tovanabutra S; Oblander T; Frost J; Sanders-Buell E; de Souza MS; Birx DL; McCutchan FE; Polonis VR
J Virol; 2005 May; 79(10):6089-101. PubMed ID: 15857994
[TBL] [Abstract][Full Text] [Related]
10. Purification and partial characterization of R5, R5X4, and X4 HIV-1 subtype C envelope glycoproteins expressed in insect cells.
Nkosi SP; Huismans H; Papathanasopoulos MA
J Med Virol; 2005 Aug; 76(4):459-63. PubMed ID: 15977243
[TBL] [Abstract][Full Text] [Related]
11. Cross-clade neutralization patterns among HIV-1 strains from the six major clades of the pandemic evaluated and compared in two different models.
Brown BK; Wieczorek L; Sanders-Buell E; Rosa Borges A; Robb ML; Birx DL; Michael NL; McCutchan FE; Polonis VR
Virology; 2008 Jun; 375(2):529-38. PubMed ID: 18433824
[TBL] [Abstract][Full Text] [Related]
12. Inter-subtype cross-neutralizing antibodies recognize epitopes on cell-associated HIV-1 virions.
Donners H; Davis D; Willems B; van der Groen G
J Med Virol; 2003 Feb; 69(2):173-81. PubMed ID: 12683404
[TBL] [Abstract][Full Text] [Related]
13. Cross-reactive neutralizing humoral immunity does not protect from HIV type 1 disease progression.
Euler Z; van Gils MJ; Bunnik EM; Phung P; Schweighardt B; Wrin T; Schuitemaker H
J Infect Dis; 2010 Apr; 201(7):1045-53. PubMed ID: 20170371
[TBL] [Abstract][Full Text] [Related]
14. High specificity of V3 serotyping among human immunodeficiency virus type-1 subtype C infected patients with varying disease status and viral phenotype.
Walker PR; Cilliers T; Choge IA; Taylor N; Cohen SS; Morris L
J Med Virol; 2006 Oct; 78(10):1262-8. PubMed ID: 16927278
[TBL] [Abstract][Full Text] [Related]
15. Conformational constraints imposed on a pan-neutralizing HIV-1 antibody epitope result in increased antigenicity but not neutralizing response.
Ho J; Uger RA; Zwick MB; Luscher MA; Barber BH; MacDonald KS
Vaccine; 2005 Feb; 23(13):1559-73. PubMed ID: 15694508
[TBL] [Abstract][Full Text] [Related]
16. Dichotomy in cross-clade reactivity and neutralization by HIV-1 sera: Implications for active and passive immunotherapy.
Cavacini LA; Duval M; Patil A; Wood C; Mayer KH; Ruprecht RM; Posner MR
J Med Virol; 2005 Jun; 76(2):146-52. PubMed ID: 15834877
[TBL] [Abstract][Full Text] [Related]
17. Neutralization patterns and evolution of sequential HIV type 1 envelope sequences in HIV type 1 subtype B-infected drug-naive individuals.
Nyambi P; Burda S; Urbanski M; Heyndrickx L; Janssens W; Vanham G; Nadas A
AIDS Res Hum Retroviruses; 2008 Dec; 24(12):1507-19. PubMed ID: 19018670
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of non-subtype C and recombinant HIV-1 viruses from Cape Town, South Africa.
Wilkinson E; Engelbrecht S
Infect Genet Evol; 2009 Sep; 9(5):840-6. PubMed ID: 19446657
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of cross-reactive HIV-1-neutralizing activity in HIV-1-infected patients with rapid or slow disease progression.
van Gils MJ; Euler Z; Schweighardt B; Wrin T; Schuitemaker H
AIDS; 2009 Nov; 23(18):2405-14. PubMed ID: 19770692
[TBL] [Abstract][Full Text] [Related]
20. Neutralizing monoclonal antibodies to human immunodeficiency virus type 1 do not inhibit viral transcytosis through mucosal epithelial cells.
Chomont N; Hocini H; Gody JC; Bouhlal H; Becquart P; Krief-Bouillet C; Kazatchkine M; Bélec L
Virology; 2008 Jan; 370(2):246-54. PubMed ID: 17920650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
